GLUTRIL 2 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Glimepiride
Medications
High-quality medicines developed to meet the therapeutic needs of today and tomorrow.
For more than 30 years, PHARMA Développement has been developing, manufacturing, and marketing medications that meet the highest standards of quality, safety, and efficacy.
Supporting patients and healthcare professionals is at the heart of our commitment. Our portfolio spans several therapeutic areas, enabling us to offer solutions tailored to the needs of the French and international markets, in compliance with regulatory requirements and with a constant focus on innovation.
Since 1991, our pharmaceutical and industrial expertise has enabled us to develop reliable, accessible medications recognized for their quality, thereby helping to improve patients’ comfort and quality of life.
The list of medications varies by region and is therefore not the same from one geographic area to another. It is also subject to change over time.
-
GLUTRIL 3 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Glimepiride
GLUTRIL 4 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Glimepiride
GLUTRIL 6 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Glimepiride
GLUTRIL M 500 mg / 2 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Glimepiride, Metformin hydrochloride
HYDROSOL Multivitamin by Pharma Développement
Therapeutic Area Nutrition and metabolism
Principes actifs Alpha-Tocopherol (Vitamin E), Ascorbic acid, Dexpanthenol, Ergocalciferol, Nicotinamide, Pyridoxine, Riboflavin, Synthetic Vitamin A, Thiamine (Vitamin B1)
MOVILIB Retard 200 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Mebeverine hydrochloride
Pylorix 140 mg, 125 mg, 125 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Metronidazole, Potassium bismuth subcitrate, Tetracycline HCl
REPAG 1 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Repaglinide
SITADIN 100 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Sitagliptin
SITADIN M 1000 mg / 50 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Metformin hydrochloride, Sitagliptin
Z+ 20 mg
Therapeutic Area Nutrition and metabolism
Principes actifs Zinc
Report
Do you wish to make a report?
In accordance with legal and regulatory obligations governing health and safety, you can report any adverse event (medicinal or cosmetic) or suspected quality defect related to the use of one of our products.
This information is crucial for the ongoing evaluation of our safety profile. Please submit your report: directly to our monitoring department via the contact form for medications; and/or via our telephone number +33 (0)3 86 20 21 64.